Rubedo members of the team. Credit: Alessandro Gandolfi/Parallelozero Alessandro Gandolfi/Parallelozero

Italian-Founded Startup Targets “Zombie Cells” to Slow Biological Aging

A 46% reduction in precancerous skin lesions in just four weeks with minimal side effects. Those are the preliminary clinical trial results for a topical cream developed by Rubedo Life Sciences, an AI-driven Silicon Valley biotech founded by Italian researchers. The startup has raised more than $70 million to date.
Credit: Shutterstock

Immigration Restrictions Fuel Surge in U.S. M&A Activity

U.S. mergers and acquisitions are surging in 2025, with Q3 bank deals hitting a four-year high and Goldman Sachs reporting a 42% jump in investment banking revenue. Beyond market confidence, tightening immigration policies are pushing companies to acquire smaller firms to secure skilled talent they can no longer hire directly. Recent research confirms that firms facing immigration restrictions are more likely to pursue domestic M&A, especially in tech and consulting.
OCTOBER 15, 2016, EDISON, NJ - Donald Trump speaks at Edison New Jersey Hindu Indian-American rally for "Humanity United Against Terror." Credit: Shutterstock.

Trump’s Megabill: What It Means for International Founders and VCs

On Tuesday, the Senate passed the latest version of the ‘One Big Beautiful Bill Act’ (OBBB), with Vice President JD Vance casting the tie-breaking vote. So, what does this mean for international entrepreneurs, startup founders, and foreign investors doing business in the U.S.?